Issue of Shares.


    03 October 2025 07:12:22
  • Source: Sharecast
RNS Number : 9820B
Wellnex Life Limited
03 October 2025
 

 

AIM Announcement                                                                                            3 October 2025

 

Wellnex Life Limited (ASX/AIM: WNX)

 

Issue of Shares

 

Wellnex Life Limited ("Wellnex" or the "Company") (ASX/AIM: WNX), announces the issue of 2,183,948 new ordinary shares of no par value in the Company ("Ordinary Shares") at a reference price of A$0.22 (£0.11) per share, in lieu of cash fees due for capital markets transaction services, including the dual listing on AIM, and investor relations purposes. 1,953,948 of the Ordinary Shares being issued are being issued to Reach Markets Pty Ltd or its nominees.

 

Admission and Total Voting Rights

Application has been made for admission of the 2,183,948 Ordinary Shares to trading on AIM. It is expected that admission will become effective and dealings in the Ordinary Shares will commence on AIM at 8.00 a.m. on or around 8 October 2025.

The new Ordinary Shares are being issued fully paid and ranking pari passu in all respects with the Company's existing Ordinary Shares.

Following Admission, the Company's issued share capital will comprise of 69,955,476 Ordinary Shares, none of which are held in treasury. Accordingly, the figure of 69,955,476 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules and the provisions of the Company's constitution.

This AIM announcement has been authorised by the Board of Wellnex Life Limited (ASX/AIM:WNX).

For further information, please contact:

 

Wellnex Life Limited (ASX:WNX)                                  Reach Markets

Zack Bozinovski                                                            T: 1300 805 795

Chief Executive Officer & Managing Director                  E: IR@reachmarkets.com.au

P: +61 3 8399 9419

E: zack.b@wellnexlife.com.au

 

UK Investors

           

Strand Hanson (Financial & Nominated Advisor)     

James Harris / Richard Johnson                                     Tel: +44 (0) 20 7409 3494

           

Orana Corporate LLP (Joint Broker)                                            swykeham@oranacorp.com

Sebastian Wykeham     

           

S.P. Angel Corporate Finance LLP (Joint Broker)                        Tel: +44 (0)20 3470 0470

David Hignell / Vadim Alexandre

 

 

To learn more, please visit: www.WellnexLife.com.au/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEQXLBBEBLBFBK

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.